Public list: Pharma Startups (4733)
CeNeRx is a specialty biopharmaceutical company developing and commercializing treatments for diseases of the central nervous system (CNS). CeNeRx is developing a balanced portfolio that includes clinical-stage therapeutics for the treatment of depre...Show all
Company (Dead / Inactive)
Phone: 919-523-0489
270 Cornerstone DR
Suite 103
Cary, 27519
North Carolina, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| CeNeRx BioPharma | $64.6M | Jun 20, 2013 |
| Astex Therapeutics | $0M | Jul 21, 2011 |
| Replidyne | $121.5M | Feb 25, 2009 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide | Jul 05, 2007 | Oct 12, 2010 | Patent |
Download PDF